{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:19:09Z","timestamp":1791890349016,"version":"4.3.4"},"reference-count":57,"publisher":"Royal College of Psychiatrists","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Approximately one in three people who use anabolic-androgenic steroids (AASs) develop dependence, characterised by both psychiatric and somatic symptoms. Despite this, AAS use disorder (AASUD) is not distinctly recognised in the latest versions of either the ICD or DSM, impeding both clinical care and research progress. It is clear that AASUD shares many features and correlates with substance use disorders (SUDs) that have specific diagnostic criteria in these classification systems, such as stimulants or opioids. We aim to outline the overlap between AASUD and more \u2018typical\u2019 SUDs as well as highlight the specific concerns related to AASUD that warrant recognition and distinct diagnostic criteria.<\/jats:p>","DOI":"10.1192\/bjp.2025.73","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T20:26:36Z","timestamp":1747081596000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":6,"title":["Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria"],"prefix":"10.1192","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-8749","authenticated-orcid":false,"given":"Morgan","family":"Scarth","sequence":"first","affiliation":[{"name":"Oslo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Amalia","family":"Havnes","sequence":"additional","affiliation":[{"name":"Oslo University Hospital"},{"name":"Institute of Clinical Medicine, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Bj\u00f8rnebekk","sequence":"additional","affiliation":[{"name":"Oslo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"S000712502500073X_ref5","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2014.912062"},{"key":"S000712502500073X_ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000528256"},{"key":"S000712502500073X_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)00104-8"},{"key":"S000712502500073X_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.02.039"},{"key":"S000712502500073X_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.09.023"},{"key":"S000712502500073X_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2007.12.002"},{"key":"S000712502500073X_ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2132"},{"key":"S000712502500073X_ref48","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718000508"},{"key":"S000712502500073X_ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00781.x"},{"key":"S000712502500073X_ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04781-1"},{"key":"S000712502500073X_ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000822"},{"key":"S000712502500073X_ref40","doi-asserted-by":"publisher","DOI":"10.1111\/add.16621"},{"key":"S000712502500073X_ref9","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0865"},{"key":"S000712502500073X_ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09751-8"},{"key":"S000712502500073X_ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2024.1347211"},{"key":"S000712502500073X_ref24","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19920101-07"},{"key":"S000712502500073X_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2012.02.014"},{"key":"S000712502500073X_ref43","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3040"},{"key":"S000712502500073X_ref49","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12688"},{"key":"S000712502500073X_ref32","doi-asserted-by":"publisher","DOI":"10.1037\/abn0000250"},{"key":"S000712502500073X_ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00247-4"},{"key":"S000712502500073X_ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06224-3"},{"key":"S000712502500073X_ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.176.4042.1399"},{"key":"S000712502500073X_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.09.023"},{"key":"S000712502500073X_ref23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1176\/ajp.145.4.487","article-title":"Affective and psychotic symptoms associated with anabolic steroid use","volume":"145","author":"Pope","year":"1988","journal-title":"Am J Psychiatry"},{"key":"S000712502500073X_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109275"},{"key":"S000712502500073X_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/add.16643"},{"key":"S000712502500073X_ref55","doi-asserted-by":"publisher","DOI":"10.1177\/1178221820904150"},{"key":"S000712502500073X_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108604"},{"key":"S000712502500073X_ref7","first-page":"31","article-title":"Anabolic-androgenic steroid dependence","volume":"50","author":"Brower","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"S000712502500073X_ref19","first-page":"500","volume-title":"Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders","year":"2024"},{"key":"S000712502500073X_ref15","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"S000712502500073X_ref4","first-page":"1120","article-title":"The prevalence of anabolic-androgenic steroid misuse in Iranian athletes: a\u00a0systematic review and meta-analysis","volume":"50","author":"Selk-Ghaffari","year":"2021","journal-title":"Iran J Public Health"},{"key":"S000712502500073X_ref12","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579411000393"},{"key":"S000712502500073X_ref17","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"key":"S000712502500073X_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107874"},{"key":"S000712502500073X_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.008"},{"key":"S000712502500073X_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2018.02.002"},{"key":"S000712502500073X_ref38","first-page":"579","article-title":"Long-term anabolic androgenic steroid use is associated with deviant brain aging","volume":"6","author":"Bj\u00f8rnebekk","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimag"},{"key":"S000712502500073X_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.01.011"},{"key":"S000712502500073X_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101691"},{"key":"S000712502500073X_ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000675"},{"key":"S000712502500073X_ref18","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","year":"1992"},{"key":"S000712502500073X_ref37","doi-asserted-by":"publisher","DOI":"10.1111\/add.14629"},{"key":"S000712502500073X_ref39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17040415"},{"key":"S000712502500073X_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109551"},{"key":"S000712502500073X_ref57","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2024.2373056"},{"key":"S000712502500073X_ref50","first-page":"100199","article-title":"Development of the Substance Use Motives Measure (SUMM): a comprehensive eight-factor model for alcohol\/drugs consumption","volume":"10","author":"Biolcati","year":"2019","journal-title":"Addict Behav Rep"},{"key":"S000712502500073X_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.01.009"},{"key":"S000712502500073X_ref16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.5.764"},{"key":"S000712502500073X_ref46","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01123"},{"key":"S000712502500073X_ref31","doi-asserted-by":"publisher","DOI":"10.3810\/psm.2009.12.1751"},{"key":"S000712502500073X_ref52","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2014.911977"},{"key":"S000712502500073X_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2022.100241"},{"key":"S000712502500073X_ref30","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1987"},{"key":"S000712502500073X_ref34","first-page":"281","article-title":"Cognition and addiction dialogues","volume":"21","author":"Verdejo-Garcia","year":"2019","journal-title":"Clin Neurosci"},{"key":"S000712502500073X_ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.11.005"}],"container-title":["The British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S000712502500073X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:29:50Z","timestamp":1785313790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S000712502500073X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S000712502500073X"],"URL":"https:\/\/doi.org\/10.1192\/bjp.2025.73","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}